Pulse Biosciences Bought 15,000: What It Means for Investors
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
Index values follow a defined daily schedule so investors know when to expect updates. This brief explains the publication times and how to use the data in your investing routine.
21,512 articlesA notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
As Hovnanian prepares to report Q2 2026 earnings, investors will scrutinize backlog, margins, and guidance. This anal...
Memory industry dynamics are shifting, and Micron stands at the center. This piece breaks down why micron technology ...
Meta Platforms is navigating a bold AI infrastructure push that could redefine profits. This guide breaks down the ri...
In the race to dominate AI inference, two hardware contenders stand out: Nvidia and Cerebras. This guide breaks down ...
MoneyHero fans will be watching the 2025 earnings with a keen eye for growth, margins, and the companys path to profi...
When a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
As AI reshapes tech investing, the question lingers: should chip stocks dip? This piece blends Jensen Huang’s long‑te...
As Chewy released its latest earnings, investors faced mixed signals: growing revenue and better margins, but cautiou...
Two former ANTM contestants weigh in as Tyra Banks sues Netflix over Reality Check editing. Their reactions illuminat...
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
In markets juggling record highs with recession fears, a few billionaire investors are doubling down on the backbone ...